IOVANCE BIOTHERAPEUTICS, INC. Debt Conversion, Original Debt, Amount
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Debt Conversion, Original Debt, Amount of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionOriginalDebtAmount1 · last filed 2016-03-11
- IOVANCE BIOTHERAPEUTICS, INC. debt conversion, original debt, amount for the quarter ending 2013-12-31 was -$2.47M.
- IOVANCE BIOTHERAPEUTICS, INC. debt conversion, original debt, amount for the quarter ending 2013-09-30 was $0.00.
- IOVANCE BIOTHERAPEUTICS, INC. debt conversion, original debt, amount for the quarter ending 2012-12-31 was -$497.89K.
- IOVANCE BIOTHERAPEUTICS, INC. debt conversion, original debt, amount for fiscal 2015 was $0.00.
- IOVANCE BIOTHERAPEUTICS, INC. debt conversion, original debt, amount for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- IOVANCE BIOTHERAPEUTICS, INC. debt conversion, original debt, amount for fiscal 2013 was $6.79M.
- IOVANCE BIOTHERAPEUTICS, INC. debt conversion, original debt, amount for fiscal 2012 was $0.00.
| Period end | Debt Conversion, Original Debt, Amount 3 month | Debt Conversion, Original Debt, Amount 6 month | Debt Conversion, Original Debt, Amount 9 month | Debt Conversion, Original Debt, Amount 12 month | Debt Conversion, Original Debt, Amount 12 month as first filed | Debt Conversion, Original Debt, Amount 69 month | Debt Conversion, Original Debt, Amount 72 month | Debt Conversion, Original Debt, Amount 78 month |
|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-03-11 | |||||||
| 2015-06-30 | $42.00 10-Q · filed 2015-08-10 | |||||||
| 2014-12-31 | $0.00 10-K · filed 2016-03-11 | |||||||
| 2014-03-31 | $6.79M 10-Q · filed 2014-05-14 | |||||||
| 2013-12-31 | -$2.47M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | -$2.47M derived: sum of 2 quarters · filed 2016-03-11 | $6.79M 10-K · filed 2016-03-11 | $6.79M 10-K · filed 2014-03-28 | $6.79M 10-K · filed 2014-03-28 | |||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $9.27M 10-Q · filed 2013-11-14 | $9.27M 10-Q · filed 2013-11-14 | |||||
| 2013-06-30 | $9.27M 10-Q · filed 2013-10-23 | $9.27M 10-Q · filed 2013-10-23 | ||||||
| 2012-12-31 | -$497.89K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $0.00 10-K · filed 2014-03-28 | ||||||
| 2012-09-30 | $497.89K 10-Q · filed 2013-01-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |